The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer-Reference-Cited by-同舟云学术

The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer

Published:2020-09 Issue: Volume:150 Page:128-135
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Wiedenmann Nicole^ORCID,Grosu Anca-Ligia,Büchert Martin^ORCID,Rischke Hans C.,Ruf Juri^ORCID,Bielak Lars^ORCID,Majerus Liette,Rühle Alexander^ORCID,Bamberg Fabian^ORCID,Baltas Dimos,Hennig Jürgen^ORCID,Mix Michael,Bock Michael^ORCID,Nicolay Nils H.^ORCID

Funder

Deutschen Konsortium für Translationale Krebsforschung

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference41 articles.

1. The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities;Walsh;Antioxid Redox Signal,2014

2. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer;Rajendran;Clin Cancer Res,2006

3. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer;Grosu;Int J Radiat Oncol Biol Phys,2007

4. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer;Zips;Radiother Oncol,2012

5. Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome;Wiedenmann;Radiother Oncol,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxiebasierte Deeskalation der Radiochemotherapie bei Patienten mit Humanem-Papillomavirus-assoziiertem Oropharynxkarzinom;Strahlentherapie und Onkologie;2024-02-23

2. Is there a role for [18F]-FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature;Clinical and Translational Imaging;2024-01-23

3. Is there a role for [18F]FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature.;2023-10-12

4. Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers;Cancers;2023-03-22

5. Advances in PET and MRI imaging of tumor hypoxia;Frontiers in Medicine;2023-02-09